Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, age, gender, weight, race, and ethnicity were not provided.Date of event: the date of the event is not known.The expiration date of the device is not known as the device lot number is not available / not reported.The device manufacture date is not known as the device lot number is not available / not reported.[conclusion]: the healthcare professional reported that at a product round table discussion on 16-nov-2021, it was reported that the 5mm x 33mm embotrap ii revascularization device (et009533 / lot# unknown) encountered difficulty during the attempt to withdrawal it through the vessel.It was not known if continuous flush was maintained.There was no report of any patient adverse event or complication.The complaint product is not available for return.Based on complaint information, the device is not available to be returned for analysis.The device lot number was not available.The manufacturing documentation review could not be performed without the lot number.Product analysis cannot be conducted as the product was not returned for analysis.No determination of causes and possible contributing factors could be made.As such, the investigation will be closed.With the limited information available and without the product available for analysis, the reported customer complaint could not be confirmed.The lot number of the device is not known, therefore review of the device history record was not performed.Assignment of root cause for the event remains speculative and inconclusive, based on the limited information provided and without the return of the complaint sample; however, it is possible that clinical and procedural factors, including device manipulation / interaction, thrombus / clot size / vessel characteristics, device selection, and the concomitant microcatheter, may have contributed to the reported issue.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
Manufacturer¿s ref.No: pc-(b)(4).The purpose of this mdr submission is to include the additional event information received on 06-dec-2021.[additional information]: the healthcare professional reported that at a product round table discussion on 16-nov-2021, it was reported that the 5mm x 33mm embotrap ii revascularization device (et009533 / lot# unknown) encountered difficulty during the attempt to withdrawal it through the vessel.It was not known if continuous flush was maintained.There was no report of any patient adverse event or complication.The complaint product is not available for return.On 06-dec-2021, additional information was received.The information indicated that the procedure date of this event is not clear.The cause of the reported withdrawal difficulty is not known nor suspected.It was confirmed that there was no adverse outcome to the patient as a result of the reported issue.The reported issue did not result in a clinically significant delay in the procedure.E.1: the initial reporter phone: (b)(6).The initial reporter email address was not available / reported.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|